AzTrials
AzTrials

StrokeNCT04936828

Ecological Momentary Intervention for Stroke Caregivers' Psychological Support

A study testing iCBT-based EMI in people with Stroke and Caregiver Burnout, run by The University of Hong Kong at 7 sites in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed trial aims to evaluate the effectiveness of internet-delivered cognitive behavioural therapy (iCBT) based ecological momentary intervention (EMI) for psychological well-being in stroke family caregivers. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Caregiver Burnout, Depressive Symptoms
What is being tested?
iCBT-based EMI
Could I receive a placebo?
No, everyone receives an active treatment
How many people
256 participants
Where
7 sitesHong Kong
Study dates
17 Sep 2021to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary family caregiver of stroke patient (modified Barthel Index [mBI] <15; usually represent moderate disability)
  • Able to read and communicate in Chinese
  • Aged ≥18
  • Able to use mobile phone text messaging function
  • PHQ-9 ranged from 5 to 19

Who cannot join

  • Professional medical personnel and professional carer
  • Has provided care for <1 month prior to recruitment
  • Has diagnosis of psychiatric disease or is currently taking psychotropic drug
  • PHQ-9 ≥ 20 (i.e., severe depressive symptom)
  • Currently participating in any type of psychological intervention (e.g., CBT)

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

Hong Kong7 sites
  • Hong Kong PHAB Association

    Hong Kong

  • Hong Kong Stroke Association

    Hong Kong

  • NT West Community Rehabilitation Day Centre

    Hong Kong

  • Queen Mary Hospital

    Hong Kong

  • The Hong Kong Society for Rehabilitation

    Hong Kong

  • Tung Wah Hospital

    Hong Kong

  • United Christian Hospital

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Ecological Momentary Intervention for Stroke Caregivers' Psychological Support: a Randomised Controlled Trial

The proposed trial aims to evaluate the effectiveness of internet-delivered cognitive behavioural therapy (iCBT) based ecological momentary intervention (EMI) for psychological well-being in stroke family caregivers.

Read the detailed description

Many stroke patients require long-term care in the community. In Hong Kong (HK), most stroke caregivers in the community are family members, and many require psychological support for caregiver stress. However, these caregivers have difficulties accessing existing centre-based services due to varying work and care responsibilities, and therefore require alternative support services to meet their unique needs and schedules. Evidence shows that internet-delivered cognitive behavioural therapy (iCBT) is effective in managing psychological distress including depressive symptoms, especially when guided by healthcare professionals. Ecological momentary intervention (EMI) is an innovative and cost-effective intervention 'framework' that utilises mobile messages to deliver personalised psychological interventions. The proposed trial aims to deliver iCBT-based EMI through instant messaging applications (e.g. WhatsApp) to provide personalised and real-time psychological support led by nurses. Screened stroke caregivers with Patient Health Questionnaire-9 (PHQ-9) scores ranging from 5 to 19 (mild to moderately severe depressive symptoms) will be recruited from community centres, rehabilitation centres and outpatient clinics in HK. They will then be individually randomised into the Intervention group (n=128) or Control group (n=128). The Intervention group will receive the iCBT-based EMI for 12 weeks, which includes instant messages sent at the times and frequencies of the participants' choosing, and chat-based psychological support led by nurses to enhance effects of iCBT through real-time counselling and practical advice. The control group will only receive instant messages on general mental health information and reminders to participate in follow-up surveys. The primary outcome is PHQ-9 scores at 24 weeks. Secondary outcomes will include anxiety, perceived stress, caregiver burden, caring experience, spiritual well-being and quality-of-daily-life. We will strictly follow the CONSORT-EHEALTH checklist. A post-trial qualitative study will be conducted to understand the participants' experience of and compliance with the EMI. The intervention will be highly applicable for all caregivers requiring psychological support and will be one step further in meeting the World Health Organization's recommendations in supporting caregivers in the context of global ageing populations.

Being tested
iCBT-based EMI
Medical subject headings
Stroke, Caregiver Burden, Depression, Cell Phone Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iCBT-based EMIOther

    Consists of brief iCBT for psychological support (mandatory), stroke care education (optional), and nurse-led real-time chat-based support messages, delivered according to participants' preferences.

Study groups in NCT04936828
Study groupRoleWhat they receive
Intervention groupExperimentalReceive iCBT based EMI with message content, delivery frequency and timing personalised to participants' preferences.
Receives: Other: iCBT-based EMI
Control groupNo interventionReceive general mental health information through instant message.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9])

    A 9-item scale with score ranging from 0 to 27, higher scores indicate higher severity of depressive symptom

    Measured: 24-week

Secondary outcomes (6)
  1. Anxiety symptoms (Generalized Anxiety Disorder-7 [GAD-7])

    A 7-item scale with score ranging from 0 to 21, higher scores indicate higher severity of anxiety symptoms

    Measured: 24-week

  2. Stress level (Perceived Stress Scale [PSS-4])

    A 4-item scale with score ranging from 0 to 16, higher scores indicate higher severity of stress

    Measured: 24-week

  3. Caregiver's burden (Zarit Burden Interview [ZBI-4])

    A 4-item scale with score ranging from 0 to 16, higher scores indicate higher severity of caregiving burden

    Measured: 24-week

  4. Caring experience (Positive Aspects of Caregiving [PAC])

    An 11-item scale with score ranging from 0 to 44, higher scores indicate more positive appraisal of caregiving experience

    Measured: 24-week

  5. Spiritual well-being (Sub-scale of Spirituality Scale for Chinese Elders [SSCE])

    An 8-item scale with score ranging from 0 to 32, higher scores indicate better spiritual well-being

    Measured: 24-week

  6. Quality of life (EuroQol 5-dimension 5-level questionnaire [EQ-5D-5L])

    A 5-item scale with predicted values ranging from -.864 to 1, higher values indicate higher health-related quality of life

    Measured: 24-week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jun 2021
  2. Study start17 Sep 2021
  3. Primary completion30 Jun 2023
  4. Study completion30 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
256 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04936828
Sponsor's protocol ID
17617620
Status last verified
Jul 2024
First submitted
15 Jun 2021
Last updated
11 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing iCBT-based EMI in people with Stroke and Caregiver Burnout, run by The University of Hong Kong at 7 sites in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9]) (time frame: 24-week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in